yourstate.us
42 CFR 410.146

§ 410.146 Diabetes outcome measurements.

United States · 42 CFR — Public Health · Status: effective

Get this as JSONEmbed this
Cite this
Citation
42 CFR 410.146, § 410.146 Diabetes outcome measurements, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/203378
Permanent ID
ys:prov:203378@1
SHA-256
8b87873ad72ed85437a77f7bbfc3dbfb2a47b4299dbb778ee608120401e5ce38

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Information collection. An approved entity must collect and record in an organized systematic manner the following patient assessment information at least on a quarterly basis for a beneficiary who receives training under § 410.141: (1) Medical information that includes the following: (i) Duration of the diabetic condition. (ii) Use of insulin or oral agents. (iii) Height and weight by date. (iv) Results and date of last lipid test. (v) Results and date of last HbA1C. (vi) Information on self-monitoring (frequency and results). (vii) Blood pressure with the corresponding dates. (viii) Date of the last eye exam. (2) Other information that includes the following: (i) Educational goals. (ii) Assessment of educational needs. (iii) Training goals. (iv) Plan for a follow-up assessment of achievement of training goals between 6 months and 1 year after the beneficiary completes the training. (v) Documentation of the training goals assessment. (b) Follow-up assessment information. An approved entity may obtain information from the beneficiary's survey, primary care physician contact, and follow-up visits.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.